INMB221021C00005000 Option on INmune Bio

INMB
 Stock
  

USD 6.81  0.41  6.41%   

INmune Bio's option chain provides insight into all available option contracts written on INmune Bio's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of INmune Bio's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given INmune option contract. View S&P 500 options
  
Purchasing INmune Bio options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" INmune calls. Remember, the seller must deliver INmune Bio stock to the call owner when a call is exercised.

In The Money vs. Out of Money Option Contracts on INmune Bio

Analyzing INmune Bio's in-the-money options over time can help investors to take a profitable long position in INmune Bio regardless of its overall volatility. This is especially true when INmune Bio's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money INmune Bio's options could be used as guardians of the underlying stock as they move almost dollar for dollar with INmune Bio's stock while costing only a fraction of its price.
INmune Bio's latest option contracts expiring on 2022-12-16 are carrying combined implied volatility of 276.54 with a put-to-call open interest ratio of 0.24 over 14 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2022-12-16. The current put volume is at 47, with calls trading at the volume of 65. This yields a 0.72 put-to-call volume ratio. The INmune Bio option chain provides detailed quote and price information for the current INmune Bio option contracts. It shows all of INmune Bio's listed puts, calls, expiration dates, strike prices, and other pricing information.

Open Interest Against 2022-12-16 Option Contracts

INmune Bio option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in INmune Bio's lending market. For example, when INmune Bio's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on INmune Bio, he or she must hedge the risk by shorting INmune Bio stock over its option's life.
The chart above shows INmune Bio's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. INmune Bio's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for INmune Bio's option, there is no secondary market available for investors to trade.
INmune Bio's stock options are financial instruments that give investors the right to buy or sell shares of INmune Bio common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell INmune stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If INmune Bio's stock price goes up or down, the stock options follow.
Please see Risk vs Return Analysis.
Please note that buying 'in-the-money' options on INmune Bio lessens the impact of time decay, as they carry both intrinsic and time value. So, even if INmune Bio's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money INmune Bio contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if INmune Stock moves the wrong way.
As of December 8, 2022, Net Income Common Stock is expected to decline to about (31.1 M)

INmune Current Options Market Mood

INmune Bio's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps INmune Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of INmune Bio's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. INmune Bio's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current INmune Bio's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Rule 16 of the current INmune contract

Base on the Rule 16, the options market is currently suggesting that INmune Bio will have an average daily up or down price movement of about 17.28% per day over the life of the 2022-12-16 option contract. With INmune Bio trading at USD6.81, that is roughly USD1.18. If you think that the market is fully incorporating INmune Bio's daily price movement you should consider buying INmune Bio options at the current volatility level of 276.54%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

INmune Bio Option Chain

When INmune Bio's strike price is surpassing the current stock price, the option contract against INmune Bio stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
2022-12-162023-01-202023-03-172023-06-16
INmune Bio's option chain is a display of a range of information that helps investors for ways to trade options on INmune. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for INmune. It also shows strike prices and maturity days for a INmune Bio against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
DeltaGammaOpen IntExpirationCurrent SpreadLast Price
Call
2022-12-16 CALL at $2.50.93970.0226142022-12-163.6 - 4.60.0In
Call
2022-12-16 CALL at $5.00.82650.1264262022-12-160.4 - 2.851.81In
 Put
2022-12-16 PUT at $7.5-0.99815.8135252022-12-160.75 - 1.450.75In
 Put
2022-12-16 PUT at $10.0-0.77580.103462022-12-161.5 - 3.93.2In
 Put
2022-12-16 PUT at $12.5-0.80770.07402022-12-165.6 - 6.45.5In
 Put
2022-12-16 PUT at $15.0-0.80650.0613392022-12-168.2 - 9.70.0In
 Put
2022-12-16 PUT at $20.0-0.90180.039102022-12-1613.2 - 14.30.0In

INmune Bio Net Income Common Stock Over Time

The amount of net income (loss) for the period due to common shareholders. Typically differs from Net Income to the parent entity due to the deduction of Preferred Dividends.
   Net Income Common Stock   
Share
       Timeline  

INmune Bio Historical Liabilities

While analyzing the current debt level is an essential aspect of forecasting the current year budgeting needs of INmune Bio, understanding its historical liability is critical in projecting INmune Bio's future earnings, especially during periods of low and high inflation and deflation. Many analysts look at the trend in assets and liabilities and evaluate how INmune Bio uses its financing power over time.

INmune Bio Investors Sentiment

The influence of INmune Bio's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in INmune. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to INmune Bio's public news can be used to forecast risks associated with investment in INmune. The trend in average sentiment can be used to explain how an investor holding INmune can time the market purely based on public headlines and social activities around INmune Bio. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
INmune Bio's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for INmune Bio's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average INmune Bio's news discussions. The higher the estimated score, the more favorable is the investor's outlook on INmune Bio.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards INmune Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, INmune Bio's short interest history, or implied volatility extrapolated from INmune Bio options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as INmune Bio using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Risk vs Return Analysis. You can also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for analysis

When running INmune Bio price analysis, check to measure INmune Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INmune Bio is operating at the current time. Most of INmune Bio's value examination focuses on studying past and present price action to predict the probability of INmune Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move INmune Bio's price. Additionally, you may evaluate how the addition of INmune Bio to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Is INmune Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of INmune Bio. If investors know INmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about INmune Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
114.9 M
Quarterly Revenue Growth YOY
6
Return On Assets
(0.19) 
Return On Equity
(0.41) 
The market value of INmune Bio is measured differently than its book value, which is the value of INmune that is recorded on the company's balance sheet. Investors also form their own opinion of INmune Bio's value that differs from its market value or its book value, called intrinsic value, which is INmune Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because INmune Bio's market value can be influenced by many factors that don't directly affect INmune Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between INmune Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine INmune Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, INmune Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.